Fibromyalgia Trial, Recruiting NCT07186751 Sponsor: Beijing Tiantan Hospital Condition: Fibromyalgia
Back to Fibromyalgia

Fibromyalgia Trial, Recruiting

NCT07186751
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You have been diagnosed with fibromyalgia (FM) using specific medical guidelines from 2010/2011, updated in 2016
  • You are older than 18 years of age
  • Your fibromyalgia pain is moderate to severe (scoring more than 4 out of 10 on a pain scale), non-drug treatments have not helped enough, and you have not yet tried the currently recommended medications for fibromyalgia
  • You are willing and able to sign a consent form agreeing to take part in the trial

Who may not be able to join:

  • You have a history of any psychiatric (mental health) condition
  • You have had an allergic reaction to, or have a medical reason not to take, the medications pregabalin or venlafaxine
  • You are currently pregnant or breastfeeding
  • You have a serious ongoing health condition, such as high blood pressure that is not well controlled, diabetes that is not well controlled, significant heart problems, or long-term liver or kidney problems
  • You have any other pain condition, whether short-term or long-term, that is separate from your fibromyalgia

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 20 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +8613611326978

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Beijing Tiantan Hospital
Registry
ClinicalTrials.gov
Start date
20 September 2025
Est. completion
30 June 2027

Where this trial is recruiting

🇨🇳 China

Primary endpoints

The average pain intensity

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 20 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov